| 1 |
CASQ1 Gene Is an Unlikely Candidate for Malignant Hyperthermia Susceptibility in the North American Population: Erratum. ( 29443706
)
|
|
2018 |
| 2 |
Voltage modulates halothane-triggered Ca<sup>2+</sup>release in malignant hyperthermia-susceptible muscle. ( 29247050
)
|
Zullo A....Melzer W.
|
2018 |
| 3 |
Functional and Structural Characterization of a Novel Malignant Hyperthermia-susceptible variant of DHPR-I^<sub>1a</sub>subunit (CACNB1). ( 29212769
)
|
Perez C.F....Casarotto M.G.
|
2017 |
| 4 |
Muscular body build and male sex are independently associated with malignant hyperthermia susceptibility. ( 28063098
)
|
Butala B....Brandom B.
|
2017 |
| 5 |
Malignant Hyperthermia Susceptibility and Related Diseases. ( 28902673
)
|
Litman R.S....Riazi S.
|
2017 |
| 6 |
Skeletal Muscle Metabolic Dysfunction in Patients With Malignant Hyperthermia Susceptibility. ( 28682948
)
|
Thompson S.J....Wells G.D.
|
2017 |
| 7 |
Idiopathic hyperCKemia and malignant hyperthermia susceptibility. ( 28952030
)
|
Santos J.M....Silva H.C.A.
|
2017 |
| 8 |
Anesthetic Management of Two Pediatric Patients With Concurrent Diagnoses of Mitochondrial Disease and Malignant Hyperthermia Susceptibility: A Case Report. ( 28604462
)
|
Nelson J.H....Kaplan R.F.
|
2017 |
| 9 |
Malignant Hyperthermia Susceptibility and Fitness for Duty. ( 28290972
)
|
Lee M.A....Capacchione J.F.
|
2017 |
| 10 |
Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosis. ( 29137581
)
|
Chan T.Y....Pollock N.A.
|
2017 |
| 11 |
A Primer for Diagnosing and Managing Malignant Hyperthermia Susceptibility. ( 28926348
)
|
Larach M.G.
|
2017 |
| 12 |
Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review. ( 28326467
)
|
Kraeva N....Riazi S.
|
2017 |
| 13 |
Hypermetabolism in B-lymphocytes from malignant hyperthermia susceptible individuals. ( 27646467
)
|
Hoppe K....Klingler W.
|
2016 |
| 14 |
A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient. ( 27555149
)
|
MacKay E.J....Kennedy T.
|
2016 |
| 15 |
Long term oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual. ( 27854207
)
|
Butala B.N....Brandom B.W.
|
2016 |
| 16 |
Using a Vulnerability Theoretical Model to Assess the Malignant Hyperthermia Susceptible Population: Implications for Advanced Practice Emergency Nurses. ( 26218487
)
|
Denholm B.G.
|
2015 |
| 17 |
Effect of caffeine on intrinsic mechanical properties of normal and malignant hyperthermia-susceptible muscle. ( 25619865
)
|
Metterlein T....Anetseder M.
|
2015 |
| 18 |
Congenital ptosis, scoliosis, and malignant hyperthermia susceptibility in siblings with recessive RYR1 mutations. ( 26691049
)
|
Albakri A....Khan A.O.
|
2015 |
| 19 |
Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy. ( 25958340
)
|
Kraeva N....Riazi S.
|
2015 |
| 20 |
European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. ( 26188342
)
|
Hopkins P.M....Urwyler A.
|
2015 |
| 21 |
Manufacturer's response to Bilmen and Gillies' manuscript entitled "Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients". ( 25342416
)
|
Orr J....Sakata D.
|
2014 |
| 22 |
Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility. ( 25086907
)
|
Roesl C....Stowell K.M.
|
2014 |
| 23 |
Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility. ( 25614869
)
|
Sambuughin N....MacLennan D.H.
|
2014 |
| 24 |
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. ( 23842196
)
|
Riazi S....Kraeva N.
|
2014 |
| 25 |
Myopathic changes in malignant hyperthermia-susceptible patients. ( 23897489
)
|
Rosenberg H.
|
2013 |
| 26 |
Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients. ( 23923663
)
|
Martin J.W....Welliver M.D.
|
2013 |
| 27 |
Analysis of histomorphology in malignant hyperthermia-susceptible patients. ( 23888335
)
|
Orlov D....Riazi S.
|
2013 |
| 28 |
Core myopathies and malignant hyperthermia susceptibility: a review. ( 23617272
)
|
Brislin R.P....Theroux M.C.
|
2013 |
| 29 |
Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations. ( 23476141
)
|
Carsana A.
|
2013 |
| 30 |
Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States. ( 23558838
)
|
Brandom B.W....Muldoon S.M.
|
2013 |
| 31 |
CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population. ( 23460944
)
|
Kraeva N....Riazi S.
|
2013 |
| 32 |
A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisis. ( 24455316
)
|
Schuster F....Anetseder M.
|
2013 |
| 33 |
Using exome data to identify malignant hyperthermia susceptibility mutations. ( 24195946
)
|
Gonsalves S.G....Biesecker L.G.
|
2013 |
| 34 |
Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. ( 23957432
)
|
Johannsen S....Schuster F.
|
2013 |
| 35 |
A family with discordance between malignant hyperthermia susceptibility and rippling muscle disease. ( 22976939
)
|
Sundblom J....Islander G.
|
2013 |
| 36 |
Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle. ( 22139840
)
|
Barrientos G.C....Pessah I.N.
|
2012 |
| 37 |
Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice. ( 22431093
)
|
Rouviere C....Ingalls C.P.
|
2012 |
| 38 |
Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals. ( 22696611
)
|
Johannsen S....Schuster F.
|
2012 |
| 39 |
Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients. ( 22577915
)
|
Jones C....Pollock N.
|
2012 |
| 40 |
A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility. ( 22030266
)
|
Taylor A....Lotery A.J.
|
2012 |
| 41 |
A medical student with malignant hyperthermia susceptibility. ( 22417041
)
|
Underwood N....Austin J.D.
|
2012 |
| 42 |
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility. ( 22480578
)
|
Lacava C....Weigl L.G.
|
2012 |
| 43 |
Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. ( 22547813
)
|
Eltit J.M....Allen P.D.
|
2012 |
| 44 |
3,4-Methylenedioxymethamphetamine (Ecstasy) increases the sensitivity of the contractile apparatus to calcium ions in both malignant hyperthermia-susceptible and normal skeletal muscle fibres. ( 22089516
)
|
Gerbershagen M.U....Zink W.
|
2012 |
| 45 |
Renal transplantation from an unrelated living donor to a malignant hyperthermia-susceptible patient: a case report. ( 23256268
)
|
Kern M.
|
2011 |
| 46 |
Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean? ( 21791992
)
|
Wappler F.
|
2011 |
| 47 |
Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice. ( 21169802
)
|
Kim T.W....Nemergut M.E.
|
2011 |
| 48 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( 21730923
)
|
Metterlein T....Anetseder M.
|
2011 |
| 49 |
Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases. ( 21376345
)
|
Metterlein T....Kranke P.
|
2011 |
| 50 |
New device simplifies workstation preparation for malignant hyperthermia-susceptible patients. ( 21791993
)
|
Feldman J.M.
|
2011 |
